(MENAFN- EIN Presswire)
Secondcell Bio is scaling up implementation of biotechnology originating from The Rockefeller University for drug discover at Scale.
Alliance Care Technologies International provides value-based healthcare solutions across the continuum of care.
Dubai Summit to create a leading drug discovery biotech hub in the United Arab Emirates.
Drug discovery summit focuses on creation of a biotech hub in the United Arab Emirates based on biotechnology from The Rockefeller University.
Chromovert® Technology is newly published, but it is not new, and that is an excellent thing: more than $100,000,000 has already been invested in perfecting it.” — Kambiz ShekdarNEW YORK, NY, USA, February 3, 2022 /EINPresswire.com / -- UAE-based Alliance Care Technologies International (ACTI) and American biotech firm Secondcell Bio™ are hosting a summit in Dubai focused on high-speed discovery of new drugs. The summit Is being convened with Emirati stakeholders, doctors, scientists, research foundations and government officials between February 1 to 12, 2022.
Chromovert ® is a proprietary biotechnology invented by Secondcell Bio™ CEO Dr. Kambiz Shekdar in the laboratory of the late Nobel-Laureate Dr. Gunter Blobel of The Rockefeller University.
According to Dr. Shekdar,“Chromovert® Technology is newly published, but it is not new, and that is an excellent thing: more than $100,000,000 has already been invested in perfecting it.'
Currently, the industry-average failure rate in the pharmaceutical industry is a staggering 98%. Chromovert® improves the likelihood of success. Dr. Blobel said, 'You can really test in a much more comprehensive way than you could previously, and therefore Chromovert will probably be important to eliminate side effects or to predict side effects and we can get better, more highly targeted drugs.'
ACTI CEO Michele Tarnow adds,“We have the privilege to work with the UAE's leading hospitals and research centers. By helping to bring Secondcell Bio™ and Dr. Shekdar's research to the UAE, we help the Emirates achieve their goal of becoming the leader in global health care by 2030. We are excited to work alongside Dr. Shekdar to bring this cutting-edge research to the UAE.
Previously, Chromovert® was used to discover a novel pain blocker fast-tracked by the FDA and presented at The White House and to create a $100M+ natural flavors discovery engine with The Coca-Cola Company, Kraft Foods and Nestle. The technology is also being used to pursue a global cure by Research Foundation to Cure AIDS (RFTCA).
About Secondcell Bio™
Secondcell Bio™ is building greater partnerships to realize the full potential of its Chromovert® Technology. Secondcell is making its technology available to researches in universities around the world. While the language of science is English, Secondcell Bio™ speaks all languages. An Arabic version of the process is enclosed. Materials and methods to operate the technology are available online at .
About Alliance Care Technologies International
Alliance Care Technologies International (ACTI) is driven by a mission to provide global access to quality healthcare. ACTI develops and deploys advanced technology and artificial intelligence solutions that solve today's most pressing healthcare challenges. We work with industry leaders to design individualized solutions that enhance the patient experience, streamline administrative processes, manage costs, and ultimately, improve healthcare outcomes. .
SECONDCELL BIO™ CCONTACT INFORMATION
Vice President of Public Affairs, J. Dianne Dotson
Technology Ambassador Elya Rizk
ALLIANCE CARE TECHNOLOGIES INTERNATIONAL CONTACT INFORMATION
+971.58.550.9179
Dianne Dotson
Secondcell Bio
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
MENAFN03022022003118003196ID1103636958
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.